Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Stereotaxis, Inc. on February 22, 2011, reporting events occurring on February 16, 2011. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
- Board Election: Dr. Joseph D. Keegan was elected to the Board of Directors on February 16, 2011.
- Compensation: Dr. Keegan will be compensated on the same basis as other non-management directors, consistent with the 2010 Proxy Statement.
- Related Party Transactions: The Company reported no transactions exceeding $120,000 since January 1, 2009, in which Dr. Keegan had a material interest.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding future activities and performance, noting that actual results may differ materially due to risks and uncertainties. The Company explicitly states it does not intend to update these statements except as required by law. No specific financial guidance or operational outlook was provided in this document.
Investor Verification Checklist
- Verify Dr. Joseph D. Keegan's professional background and qualifications.
- Review the Company's 2010 Proxy Statement for details on the standard director compensation package.
- Confirm the date of the press release (February 22, 2011) referenced in Item 7.01.
- Check subsequent filings for Dr. Keegan's specific committee assignments, which were pending at the time of this report.